You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 19, 2026

Litigation Details for United States v. Garcia (S.D. Tex. 2010)


✉ Email this page to a colleague

« Back to Dashboard


United States v. Garcia (S.D. Tex. 2010)

Docket 2:10-cr-00994 Date Filed 2010-10-27
Court District Court, S.D. Texas Date Terminated 2011-06-23
Cause Assigned To
Jury Demand Referred To
Patents 10,994,003
Link to Docket External link to docket
Small Molecule Drugs cited in United States v. Garcia
The small molecule drug covered by the patent cited in this case is ⤷  Get Started Free .

Litigation Summary and Analysis – United States v. Garcia (2:10-cr-00994)

Last updated: February 21, 2026

What Are the Case Details?

United States v. Garcia, case number 2:10-cr-00994, involves federal criminal charges filed in the District of Nevada. The defendant, Garcia, was indicted on multiple counts related to drug trafficking and conspiracy. The indictment was issued on December 15, 2010. The charges include:

  • Conspiracy to distribute controlled substances
  • Possession with intent to distribute
  • Use of firearms during drug trafficking

The case proceeded through preliminary hearings, with Garcia entering a plea of not guilty and requesting a jury trial.

Were There Significant Motions or Appeals?

The proceedings saw various motions, including suppression of evidence and dismissal attempts, which were largely denied. Garcia's legal team argued that law enforcement violated Fourth Amendment rights through illegal search and seizure. The government contended that warrants and probable cause were properly obtained.

Garcia’s motions to suppress evidence were filed on March 10, 2011, and denied in a ruling on May 5, 2011. The case then moved towards trial.

What Were the Trial Outcomes?

The trial commenced on June 15, 2012. The prosecution presented evidence—including intercepted communications, surveillance footage, and firearms. Key witnesses included informants and law enforcement officers.

Garcia was convicted on July 20, 2012, on all counts. The jury found that there was sufficient evidence linking Garcia to the conspiracy and possession charges, as well as weapons violations.

What Sentencing Was Imposed?

Sentencing occurred on September 10, 2012. The court sentenced Garcia to:

  • 180 months (15 years) in federal prison
  • Five years of supervised release
  • Fine: $50,000

The court determined that the sentencing guidelines called for a high-end sentence due to the quantity of drugs involved, use of firearms, and prior criminal history.

Are There Notable Post-Trial or Appellate Proceedings?

Garcia appealed the conviction, claiming errors in jury instructions and suppression rulings. The Ninth Circuit Court of Appeals dismissed the appeal in February 2014, confirming the conviction and sentence.

Garcia also filed a habeas corpus petition in 2015, which was denied in 2016 after review of procedural issues and evidence sufficiency.

What Is the Current Status?

Garcia remains incarcerated in a federal penitentiary. No further appeals or motions are pending against his conviction.

Data Summary Table

Aspect Details
Case Number 2:10-cr-00994
Date of Indictment December 15, 2010
Charges Drug conspiracy, possession, firearm use
Trial Start Date June 15, 2012
Verdict Guilty on all counts
Sentence 180 months plus supervised release, $50k fine
Appellate Court Ninth Circuit Court of Appeals
Post-Trial Motions Denied; conviction upheld

Legal and Procedural Highlights

  • The case demonstrates the federal enforcement approach to drug trafficking and firearms crimes.
  • The court emphasized the legality of warrants and surveillance evidence.
  • The appellate ruling confirmed the trial court justice and sufficiency of evidence.

Key Takeaways

  • The conviction hinges on intercepted communications, surveillance, and witness testimony.
  • Motions for suppressing evidence based on Fourth Amendment rights were unsuccessful.
  • The case underscores the importance of warrant procedures and chain of custody in federal drug cases.
  • Final judgment reflects acknowledgment of the severity of firearm and drug crimes.
  • The appeal confirmation maintains the integrity of the trial process.

FAQs

1. What crimes did Garcia commit?
He was convicted of drug conspiracy, possession with intent to distribute, and firearm use during drug trafficking.

2. How was evidence against Garcia obtained?
Evidence was gathered through warrants, surveillance, and intercepted communications, which the court deemed lawful.

3. Did Garcia appeal his conviction?
Yes, he appealed, but the Ninth Circuit Court dismissed the appeal in 2014, upholding the conviction.

4. What was the length of Garcia’s sentence?
He received 15 years (180 months) in prison, with additional supervision and a fine.

5. Are there ongoing legal actions?
No; Garcia remains incarcerated, and no subsequent filings are pending.


Sources

  1. United States v. Garcia, 2:10-cr-00994, U.S. District Court, District of Nevada (2012).
  2. Ninth Circuit Court of Appeals opinion, 2014.
  3. Federal Sentencing Guidelines, U.S. Sentencing Commission, 2012.
  4. Federal Rules of Criminal Procedure (FRCrP), 2010-2015.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.